Association Between T Lymphocyte Mitochondrial Function and Disease Activity in Anti-NMDAR Encephalitis
Abstract
Objective
To investigate mitochondrial functional alterations in T lymphocytes of patients with anti-N-methyl-D-aspartate receptor encephalitis (anti-NMDAR encephalitis, NMDAR-E) and their association with immune exhaustion.
Methods
Twenty-five patients with NMDAR-E diagnosed in the Department of Neurology, West China Hospital, Sichuan University, between January and March 2025 (14 mild cases and 11 severe cases) and 16 healthy controls were enrolled. Flow cytometry was performed to characterize immune-cell distributions in paired peripheral blood and cerebrospinal fluid (CSF), and to evaluate the percentage of cells with low mitochondrial membrane potential (MMP-Low%), mitochondrial mass (MM), and PD-1 expression.
Results
In severe patients, the proportions of CD3+ and CD4+ T cells in CSF, the MMP-Low% of CD3+, CD4+, and CD8+ T cells (P < 0.01), and the MM of CD3+ (P < 0.01) and CD8+ T cells (P < 0.05) were all significantly higher than those in matched peripheral blood. Compared with healthy controls, the MMP-Low% of naïve and central memory CD4+ and CD8+ T-cell subsets in peripheral blood was significantly decreased (P < 0.05), whereas the proportion of PD-1-positive cells was significantly increased in CD4+naïve and central memory T-cell subsets (P < 0.01).
Conclusion
CSF T cells in patients with anti-NMDAR encephalitis display a state of dysfunctional mitochondrial accumulation, suggesting a possible dysregulation of mitochondrial mass homeostasis under the central inflammatory milieu. Mitochondrial features of peripheral T cells indicate the presence of systemic immune exhaustion. The MMP-Low% of CSF CD8+ T cells and the peripheral blood lymphocyte percentage may serve as potential immunometabolic biomarkers for distinguishing disease severity in NMDAR-E.
Keywords: Anti-NMDAR encephalitis, T-lymphocytes, Mitochondria, PD-1
Full Text:
PDFReferences
Chinese Society of Neurology, Neuroinfectious Diseases and CSF Cytology Group. Chinese expert consensus on diagnosis and treatment of autoimmune encephalitis (2022 edition). Chin J Neurol, 2022, 55(9): 931-949. doi: 10.3760/cma.j.cn113694-20220219-00118.
REN H, FAN S, ZHAO Y, et al. The changing spectrum of antibody-mediated encephalitis in China. J Neuroimmunol, 2021, 361: 577753. doi: 10.1016/j.jneuroim.2021.577753.
SEERY N, BUTZKUEVEN H, O'BRIEN T J, et al. Contemporary advances in anti-NMDAR antibody (Ab)-mediated encephalitis. Autoimmun Rev, 2022, 21(4): 103057. doi: 10.1016/j.autrev.2022.103057.
WAGNON I, HÉLIE P, BARDOU I, et al. Autoimmune encephalitis mediated by B-cell response against N-methyl-d-aspartate receptor. Brain, 2020, 143(10): 2957-2972. doi: 10.1093/brain/awaa250.
GONG X, CHEN C, LIU X, et al. Long-term functional outcomes and relapse of anti-NMDA receptor encephalitis: a cohort study in Western China. Neurol Neuroimmunol Neuroinflamm, 2021, 8(2): e958. doi: 10. 1212/NXI.0000000000000958.
JONES B E, TOVAR KR, GOEHRING A, et al. Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors. Sci Transl Med, 2019, 11(500): eaaw0044. doi: 10.1126/scitranslmed.aaw0044.
LI S, HU X, YANG Y, et al. Single-cell analyses of CSF and PBMCs from anti-NMDAR encephalitis patients reveals distinct characteristics of T cell subpopulations. medRxiv, 2024: 2023.07.27.23292878. doi: 10.1101/2023. 07.27.23292878.
WANG M, WANG J, ZHAI J, et al. Peripheral T-cell subset activation in NMDAR encephalitis: insights into pathogenesis and biomarker potential for disease monitoring. Clin Immunol, 2025, 277: 110506. doi: 10.1016/j. clim.2025.110506.
YU Y, WU Y, CAO X, et al. The clinical features and prognosis of anti-NMDAR encephalitis depends on blood brain barrier integrity. Mult Scler Relat Disord, 2021, 47: 102604. doi: 10.1016/j.msard.2020.102604.
QIAN L, ZHU Y, DENG C, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases. Signal Transduct Target Ther, 2024, 9(1): 50. doi: 10.1038/s41392-024-01756-w.
QIAO S, WANG J, ZHANG S C, et al. Immune inflammatory regulation in anti-NMDAR encephalitis: insights from transcriptome analysis. Front Neurol, 2025, 16: 1568274. doi: 10.3389/fneur.2025.1568274.
CHENG L, JIA B, WANG C, et al. Immunotherapy for autoimmune encephalitis. Cell Death Discov, 2025, 11(1): 207. doi: 10.1038/s41420-025-02459-z.
WU H, ZHAO X, HOCHREIN S M, et al. Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming. Nat Commun, 2023, 14(1): 6858. doi: 10.1038/s41467-023-42634-3.
PERALTA R M, XIE B, LONTOS K, et al. Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism. Nat Immunol, 2024, 25(12): 2297-2307. doi: 10.1038/s41590-024-01999-3.
ZOROVA L D, DEMCHENKO E A, KORSHUNOVA G A, et al. Is the mitochondrial membrane potential (∆Ψ) correctly assessed? Intracellular and intramitochondrial modifications of the ∆Ψ probe, rhodamine 123. Int J Mol Sci, 2022, 23(1): 482. doi: 10.3390/ijms23010482.
KHANNA S, PADHAN P, JAISWAL K S, et al. Altered mitochondrial proteome and functional dynamics in patients with rheumatoid arthritis. Mitochondrion, 2020, 54: 8-14. doi: 10.1016/j.mito.2020.06.005.
MIN S H, ZHOU J. smplot: An R package for easy and elegant data visualization. Front Genet, 2021, 12: 802894. doi: 10.3389/fgene.2021. 802894.
WANG B, CHEN Z, HUANG Y, et al. Mitochondrial mass of circulating NK cells as a novel biomarker in severe SARS-CoV-2 infection. Int Immunopharmacol, 2023, 124(Pt A): 110839. doi: 10.1016/j.intimp. 2023.110839.
CALLENDER L A, CARROLL E C, BOBER E A, et al. Mitochondrial mass governs the extent of human T cell senescence. Aging Cell, 2020, 19(2): e13067. doi: 10.1111/acel.13067.
LIU Z, YIN B, XU L, et al. Mitochondria-related parameters of lymphocyte subsets can distinguish different disease stages in patients with HBV infection. Sci Rep, 2025, 15(1): 21008. doi: 10.1038/s41598-025-05922-0.
MIWA S, KASHYAP S, CHINI E, et al. Mitochondrial dysfunction in cell senescence and aging. J Clin Invest, 2022, 132(13): e158447. doi: 10.1172/JCI158447.
HAN H S, LUBETZKY M L. Immune monitoring of allograft status in kidney transplant recipients. Front Nephrol, 2023, 3: 1293907. doi: 10. 3389/fneph.2023.1293907.
LIU R, DU S, ZHAO L, et al. Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target. Front Immunol, 2022, 13: 996469. doi: 10.3389/fimmu.2022.996469.
NISHIHARA H, PERRIOT S, GASTFRIEND B D, et al. Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis. Brain, 2022, 145(12): 4334-4348. doi: 10.1093/brain/awac019.
PLATT M P, BOLDING K A, WAYNE C R, et al. Th17 lymphocytes drive vascular and neuronal deficits in a mouse model of postinfectious autoimmune encephalitis. Proc Natl Acad Sci U S A, 2020, 117(12): 6708-6716. doi: 10.1073/pnas.1911097117.
WU Q, XIE Q, LIU L, et al. Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis. Mult Scler Relat Disord, 2023, 74: 104697. doi: 10.1016/j.msard.2023.104697.
SCHURICH A, PALLETT L J, JAJBHAY D, et al. Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host. Cell Rep, 2016, 16(5): 1243-1252. doi: 10.1016/j.celrep.2016.06.078.
WEI C, YUAN X, LIU X, et al. Mitochondrial fission protein 1 in the regulation of mitochondrial quality control: a cancer perspective. Interdiscip Med, 2025, 3: e20240033. doi: 10.1002/INMD.20240033.
SAGGAU C, BACHER P, ESSER D, et al. Autoantigen-specific CD4+ T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases. Immunity, 2024, 57(10): 2416-2432.e8. doi: 10.1016/j.immuni.2024.08.005.
Refbacks
- There are currently no refbacks.
